Oskarshamn, Sweden
The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study
It is estimated to include 4000 patients with myocardial infarction during 2 years. Patients will wear the accelerometer for 7 days at follow-up visits (2 months and 1 year) after discharge. The investigators will examine the dose-response relations of several exposure variables from the accelerometer measurements with the outcomes.
Phase
N/ASpan
366 weeksSponsor
Sahlgrenska University HospitalOskarshamn
Recruiting
Remote Exercise SWEDEHEART Study
Due to the covid-19 pandemic, this study will be performed in two steps: 1). National feasibility and safety study. 2). National multicenter registry-based cluster randomized crossover clinical trial (RRCT). 1. In the feasibility study, patients will be offered remote exCR at all participating sites until the peak of the pandemic has been achieved and care goes back to normal. The feasibility study will include patients until Aug 2022. 2. CR centers (not patients) will be cluster randomized to either the intervention or control. Patients at intervention centers will be offered remote exCR, usual care centre-based exCR, or a combination of both modes, as self-preferred choice. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months. Long-term follow-up will be performed 1 year and 3 years after the index cardiac event.
Phase
N/ASpan
435 weeksSponsor
Sahlgrenska University Hospital, SwedenOskarshamn
Recruiting
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Phase
3Span
475 weeksSponsor
Uppsala UniversityOskarshamn
Recruiting